A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib Journal Article


Authors: Patel, T. V.; Morgan, J. A.; Demetri, G. D.; George, S.; Maki, R. G.; Quigley, M.; Humphreys, B. D.
Article Title: A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib
Keywords: signal transduction; unclassified drug; gene deletion; sorafenib; bevacizumab; sunitinib; drug dose reduction; drug efficacy; drug withdrawal; hypertension; nonhuman; solid tumor; antineoplastic agents; benzenesulfonates; pyridines; receptors, vascular endothelial growth factor; drug targeting; antineoplastic agent; letter; biological marker; metabolism; gastrointestinal stromal tumor; stem cell factor receptor; vasculotropin receptor; edema; nephrotoxicity; protein kinase inhibitor; antineoplastic activity; drug effect; platelet derived growth factor receptor; vasculotropin inhibitor; protein kinase inhibitors; hypoalbuminemia; drug mechanism; kidney function; gene disruption; chemically induced disorder; antiangiogenic therapy; glomerulonephritis; antihypertensive agent; indoles; pyrroles; protein urine level; indole derivative; proteinuria; thrombotic thrombocytopenic purpura; pyrrole derivative; benzenesulfonic acid derivative; pyridine derivative; hemangioendothelioma; preeclampsia; blood pressure monitoring; capillary endothelium; krn 951; podocyte; preeclampsia like syndrome; renovascular disease; teratocarcinoma
Journal Title: JNCI: Journal of the National Cancer Institute
Volume: 100
Issue: 4
ISSN: 0027-8874
Publisher: Oxford University Press  
Date Published: 2008-02-01
Start Page: 282
End Page: 284
Language: English
DOI: 10.1093/jnci/djm311
PUBMED: 18270341
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 40" - "Export Date: 17 November 2011" - "CODEN: JNCIA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Maki
    238 Maki